NHS National Framework Tenofovir alafenamide/Emtricitabine 200/10mg & 200/25mg
key details
| Value | £59,625,000 (£71,550,000 inc. VAT) |
|---|---|
| Status | planned |
| Category (CPV) | 33600000 |
| Region | North East, North West, East Midlands, West Midlands, East of England, South East, South West |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-0668be |
description
Project title: NHS National Framework Tenofovir alafenamide/Emtricitabine 200/10mg & 200/25mg
Offer reference number: CM/TNS/26/5744
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/26/5744 Tenofovir alafenamide/Emtricitabine 200/10mg & 200/25mg
Lot 1 LNW 1 February 2027 to 31 October 2028 (21 months)
Lot 2 DNE & SOFE 1 February 2027 to 31 October 2028 (21 months)
Lot 3 DNW & MAE 1 February 2027 to 31 October 2028 (21 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 12 Mar 2026 | Pipeline notice (UK1) | Procurement Act 2023 | 022492-2026 |
| 26 Mar 2026 | Pipeline notice (UK1) | Procurement Act 2023 | 028180-2026 |
| 28 May 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 050056-2026 |
| 9 Jun 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 054123-2026 |
more from NHS England
- Coaching services for trainee doctors, dentists and pharmacists · £36,000 · 30 Jul 2026
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.